GB9921938D0 - Target for antiviral therapy - Google Patents

Target for antiviral therapy

Info

Publication number
GB9921938D0
GB9921938D0 GBGB9921938.8A GB9921938A GB9921938D0 GB 9921938 D0 GB9921938 D0 GB 9921938D0 GB 9921938 A GB9921938 A GB 9921938A GB 9921938 D0 GB9921938 D0 GB 9921938D0
Authority
GB
United Kingdom
Prior art keywords
target
antiviral therapy
antiviral
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9921938.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of York
Original Assignee
University of York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of York filed Critical University of York
Priority to GBGB9921938.8A priority Critical patent/GB9921938D0/en
Publication of GB9921938D0 publication Critical patent/GB9921938D0/en
Priority to PCT/GB2000/003568 priority patent/WO2001021645A2/en
Priority to AU73008/00A priority patent/AU7300800A/en
Priority to EP00960836A priority patent/EP1409524A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB9921938.8A 1999-09-17 1999-09-17 Target for antiviral therapy Ceased GB9921938D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB9921938.8A GB9921938D0 (en) 1999-09-17 1999-09-17 Target for antiviral therapy
PCT/GB2000/003568 WO2001021645A2 (en) 1999-09-17 2000-09-18 Target for antiviral therapy
AU73008/00A AU7300800A (en) 1999-09-17 2000-09-18 Target for antiviral therapy
EP00960836A EP1409524A2 (en) 1999-09-17 2000-09-18 Target for antiviral therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9921938.8A GB9921938D0 (en) 1999-09-17 1999-09-17 Target for antiviral therapy

Publications (1)

Publication Number Publication Date
GB9921938D0 true GB9921938D0 (en) 1999-11-17

Family

ID=10861054

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9921938.8A Ceased GB9921938D0 (en) 1999-09-17 1999-09-17 Target for antiviral therapy

Country Status (4)

Country Link
EP (1) EP1409524A2 (en)
AU (1) AU7300800A (en)
GB (1) GB9921938D0 (en)
WO (1) WO2001021645A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7167801B2 (en) 2001-07-12 2007-01-23 Boehringer Ingelheim (Canada) Ltd. Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates
ES2411059T3 (en) 2007-05-31 2013-07-04 Academisch Ziekenhuis Leiden H.O.D.N. Lumc Targeted HPV epitopes of T cells that infiltrate cervical malignancies for use in vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5978740A (en) * 1995-08-09 1999-11-02 Vertex Pharmaceuticals Incorporated Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying them

Also Published As

Publication number Publication date
WO2001021645A2 (en) 2001-03-29
WO2001021645A3 (en) 2001-08-16
AU7300800A (en) 2001-04-24
EP1409524A2 (en) 2004-04-21

Similar Documents

Publication Publication Date Title
HK1200316A1 (en) Therapeutic microfoams
SI1225874T1 (en) Antiviral solid dispersions
EP1187827A4 (en) Antiviral agents
IL144171A0 (en) Quinolinecarboxamides as antiviral agents
GB9930570D0 (en) Therapy
GB9907243D0 (en) Therapy
IL148889A0 (en) Set defence means
GB9911802D0 (en) Therapeutic combination
GB9911803D0 (en) Therapeutic combination
GB9900222D0 (en) Therapeutic compounds
GB9911804D0 (en) Therapeutic combination
GB9921938D0 (en) Target for antiviral therapy
GB9924981D0 (en) Gene therapy
GB9900009D0 (en) Gene therapy
GB0406539D0 (en) Gene therapy
IL127826A0 (en) Restenosis drug therapy
GB9911238D0 (en) Therapeutic use
GB0012497D0 (en) Antiviral therapy
GB0000683D0 (en) Antiviral treatment
GB9903560D0 (en) Therapy
GB9924713D0 (en) Therapy
GB9903473D0 (en) Therapy
GB9921063D0 (en) Therapy
AU5686900A (en) Antiviral tetrahydroisichinolinsulfonamides
GB9914952D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)